Literature DB >> 2976620

Induction of the in vitro anti-HBs response by hepatitis B surface antigen.

L G Filion1, R Saginur.   

Abstract

The production in vitro of antibody to hepatitis B surface antigen by peripheral blood mononuclear cells of healthy volunteers was studied after each of the three doses of hepatitis B vaccine. An in vitro hepatitis B surface antigen antibody response was successfully induced in 12% of the specimens taken over a 7 month period. The response to this antigen was induced in additional samples if cells had been treated previously with anti-CD4 and complement or anti-CD8 and complement prior to culture initiation. The addition of interleukin 2 could also induce the formation of antibodies to hepatitis B surface antigen. The results suggest that the antibody response to hepatitis B surface antigen is complex and varies depending on the individual and time of sampling.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976620      PMCID: PMC1542013     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection.

Authors:  V Barnaba; M Levrero; A D Van Dyke; A Musca; C Cordova; F Balsano
Journal:  Clin Immunol Immunopathol       Date:  1985-03

2.  Alterations in the immune response of nonresponders to the hepatitis B vaccine.

Authors:  M J Nowicki; M J Tong; R E Bohman
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

3.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

4.  Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.

Authors:  L G Filion; R Saginur; N Szczerbak
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

5.  Activation and immunoregulation of antigen-specific human b lymphocyte responses: multifaceted role of the monocyte.

Authors:  T L Gerrard; A S Fauci
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

6.  Unimpaired B-cell function and T-cell regulation of immunoglobulin synthesis in patients with chronic hepatitis B virus infection.

Authors:  P Kerlin; K M Nies; M J Tong
Journal:  Clin Immunol Immunopathol       Date:  1982-11

7.  Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies.

Authors:  E Celis; V R Zurawski; T W Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

8.  Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.

Authors:  G M Dusheiko; J H Hoofnagle; W G Cooksley; S P James; E A Jones
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

10.  Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; S M Friedman; P C Kung; G Goldstein; L Chess
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.